Oestrogen receptor status of primary breast carcinomas and their metastases. Relation to pattern of spread and survival after recurrence.
about
Discordance in hormone receptor status among primary, metastatic, and second primary breast cancers: biological difference or misclassification?Human breast cancer: survival from first metastasis. Breast Cancer Study Group.Characterizing tumors using metabolic imaging: PET imaging of cellular proliferation and steroid receptors.Prospective comparison of switches in biomarker status between primary and recurrent breast cancer: the Breast Recurrence In Tissues Study (BRITS).Datamining approach for automation of diagnosis of breast cancer in immunohistochemically stained tissue microarray images.Determination of estrogen receptors in paraffin-embedded tissue. Techniques and the value in breast cancer treatment.Absence of progesterone receptor associated with secondary breast cancer in postmenopausal women.Steroid receptors in breast cancer.Variation in hormone receptor and HER-2 status between primary and metastatic breast cancer: review of the literature.Predictive value of tumor estrogen and progesterone receptor levels in postmenopausal women with advanced breast cancer treated with toremifene.Variability in hormone and growth factor receptor expression in primary versus recurrent, metastatic, and post-neoadjuvant breast carcinoma.Estrogen, progesterone, and HER2/neu receptor discordance between primary and metastatic breast tumours-a review.Identification of estrogen-responsive genes involved in breast cancer metastases to the bone.Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases.Prognostic significance of liver metastases as first site of generalisation in patients with breast cancer--a retrospective analysis.Steroid hormone receptor activity of primary human breast cancer and pattern of first metastasis. The Breast Cancer Study Group.Immunohistochemically defined subtypes and outcome in occult breast carcinoma with axillary presentation.Treatment of breast adenocarcinoma metastasis to the neck: dedifferentiation of the tumor as suggested by hormone markers.Immunohistochemical profiles of brain metastases from breast cancer.Prognostic factors for patients with liver metastases from breast cancer.Identification of oestrogen, progesterone receptor and human epidermal growth factor receptor 2 expression in mediastinal metastases of breast cancer obtained by endobronchial ultrasound-guided transbronchial needle aspiration.Receptor Conversion in Distant Breast Cancer Metastases: A Systematic Review and Meta-analysis.Expression of pS2 protein in endometrial carcinomas: correlation with clinicopathologic features and sex steroid receptor status.Should liver metastases of breast cancer be biopsied to improve treatment choice?Stability of estrogen receptor status in breast carcinoma: a comparison between primary and metastatic tumors with regard to disease course and intervening systemic therapy.When to order a biopsy to characterise a metastatic relapse in breast cancer.
P2860
Q33699614-C9E96F3F-4217-4DA3-8302-25F47BBE576BQ33978475-F03EAD71-AD82-4F71-8F4F-667BB09509B0Q33995787-18313BDC-2CD3-4617-A8EE-9AD8A1ABAE4DQ34613506-2B7AD37E-9BA8-4A60-BE84-310BF84CAAD1Q34982979-E51A2276-656B-4F47-97A0-BE769148C31CQ35158293-4EFE8112-6F23-4AD8-8102-F6A3CC264E56Q36619003-E9341FC7-31A7-44A0-8259-E6AB646B3565Q37769581-0B9562E7-F5A6-4C0B-9E66-F253D75BEA3CQ37812122-DBCB671E-DAC2-40E5-A63B-4B589ABD884FQ37862484-94FD2256-4B46-4546-8355-72DBC3CDAE94Q38000948-199C1773-D077-4DA5-8249-393538C78F69Q38842674-E392774A-F7CB-4901-B8F4-F413FF452D53Q40115101-2EFFF7D5-31AF-4AE4-801A-7E5EDCF58FB8Q43254569-9C2B6045-D492-4B9C-BBEC-0D8FA06B6397Q43844273-22DFBFC8-C0C7-445A-9D61-ED541BEF717BQ44160812-E8A9A8B8-4E14-4D1A-AD15-E0B9F05F9665Q44543667-96113B12-0172-4330-8210-B302178DF325Q46168333-C184234B-CD71-436A-B7B7-FF4E32606C70Q46467683-53384B5F-44F2-4E08-8172-2BCC7FF59AF4Q46829269-60F78930-511E-4282-A2F9-65F5E88A3E57Q48336597-22955606-6FF4-4050-89AA-A3A032D88D85Q50120368-8887B042-DE03-4F8F-BFB8-993D5A565717Q50946948-7562AB10-6498-477A-8DBB-89AB74A069C5Q51054351-331D0195-6681-4D8F-BBC5-6341B422DEF3Q54400297-6ED16081-A03F-41A1-B918-8CF7420515F6Q54481754-DAFF7D7E-F4AA-4311-BAA3-C42DE2D51B7F
P2860
Oestrogen receptor status of primary breast carcinomas and their metastases. Relation to pattern of spread and survival after recurrence.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Oestrogen receptor status of p ...... and survival after recurrence.
@ast
Oestrogen receptor status of p ...... and survival after recurrence.
@en
type
label
Oestrogen receptor status of p ...... and survival after recurrence.
@ast
Oestrogen receptor status of p ...... and survival after recurrence.
@en
prefLabel
Oestrogen receptor status of p ...... and survival after recurrence.
@ast
Oestrogen receptor status of p ...... and survival after recurrence.
@en
P2093
P2860
P356
P1476
Oestrogen receptor status of p ...... and survival after recurrence.
@en
P2093
Kristensen B
Rasmussen BB
P2860
P2888
P304
P356
10.1038/BJC.1989.264
P407
P577
1989-08-01T00:00:00Z
P5875
P6179
1003975700